No link found between genetic risk factors and two top wet AMD treatments
Tuesday, February 12, 2013 - 16:00
in Health & Medicine
New findings from a landmark clinical trial show that although certain gene variants may predict whether a person will develop age-related macular degeneration (AMD), these genes do not predict patients' responses to Lucentis™ and Avastin™, two medications widely used to treat "wet" AMD.